Experimental IGF-I receptor deficiency generates a sexually dimorphic pattern of organ-specific growth deficits in mice, affecting fat tissue in particular

Endocrinology

Volumn 142, Issue 10, 2001, Pages 4469-4478

  Holzenberger, M ^a   Hamard, G ^a   Zaoui, R ^a   Leneuve, P ^a   Ducos, B ^a   Beccavin, C ^a   Perin L ^a   Bouc, Y L ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C RECEPTOR;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE DEVELOPMENT; BRAIN; CONNECTIVE TISSUE; CONTROLLED STUDY; FEMALE; GROWTH RATE; GROWTH RETARDATION; HEART; LIPID COMPOSITION; LUNG; MALE; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; ORGAN GROWTH; ORGAN SIZE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SEX DIFFERENCE; SKIN; SPLEEN;

EID: 0034815223     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.10.8461     Document Type: Article

References (46)

1. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting
2. Actions of IGF system proteins from studies of transgenic and gene knockout models
3. IGF-I receptor function: Transducing the IGF-I signal into intracellular events
4. Molecular biology of the type I IGF receptor
5. Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: Manipulation using the Cre/loxP system in transgenic mice
6. Normal growth and development in the absence of hepatic insulin-like growth factor I
7. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
8. Inducible gene targeting in mice
9. Recent advances in gene mutagenesis by site-directed recombination
10. Ten years of gene targeting: Targeted mouse mutants, from vector design to phenotype analysis
11. Partial invalidation and dosage of the IGF type I receptor gene via homologous and Cre-lox recombination results in postnatal proportionate dwarfism
12. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and type I IGF receptor (Igf1r)
13. Role of insulin-like growth factors in embryonic and postnatal growth
14. IGF-I is required for normal embryonic growth in mice
15. Inactivation of the IGF-I gene in mice results in perinatal lethality
16. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons
17. Effects of Igf1 gene deletion on postnatal growth patterns
18. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice
19. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice
20. Overexpression of IGF-I in the heart is coupled with myocyte proliferation in transgenic mice
21. A targeted partial invalidation of the insulin-like growth factor I receptor gene in mice causes a postnatal growth deficit
22. Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles
23. Cre recombinase: The universal reagent for genome tailoring
24. Co-regulation of two gene activities by tetracycline via a bidirectional promoter
25. Conditional mutagenesis in mice with heat shock promoter-driven cre transgenes
26. 3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: Binding characteristics in rodent brains and comparison with [3H]SNF 8702
27. Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: Repercussions on reproduction, ante- and perinatal mortality and postnatal growth
28. EMK protein kinase-null mice: Dwarfism and hypofertility associated with alterations in the somatotrope and prolactin pathways
29. Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF binding proteins (IGFBPs) produced by rat liver in culture. Estimation of serum IGFBP levels
30. Analysis of serum insulin-like growth factor binding proteins using western blotting: Use of the method for titration of the binding protein and competitive binding studies
31. Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling
32. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds
33. Sex steroids, growth hormone, insulin-like growth factor-1: Neuroendocrine and metabolic regulation in puberty
34. Sexual dimorphism of the somatotrophic axis
35. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by growth hormone in rat white adipose tissue
36. Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action
37. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle α-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia
38. Insulin-like growth factor I (IGF-I) regulates IGF binding protein-5 gene expression in the brain
39. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes
40. The role of growth hormone/insulin-like growth factors in adipocyte differentiation
41. Action of growth hormone in adipose tissue
42. Adipocyte development is dependent upon stem cell recruitment and proliferation of preadipocytes
43. Impaired adipogenesis in insulin-like growth factor binding protein-1 transgenic mice
44. Lack of insulin receptor affects the formation of white adipose tissue in mice. A morphometric and ultrastructural analysis